MILLER CHARLES,KLOS ANTHONY,ALLGAIER ERIC,ZIMMERMAN THOMAS P,WEE KEVIN,StPETER MICHELLE,GLANCY KELLY,REBBEOR JAMES
申请号：
IL26792319
公开号：
IL267923D0
申请日:
2019.07.08
申请国别(地区):
IL
年份:
2020
代理人:
摘要：
Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
